Home/Publication/Japan Post Investment Joins Catalys Pacific & SR One in Renal Biopharma
Japan Post Investment Joins Catalys Pacific & SR One in Renal Biopharma 

18 Jul 2024

US$ 19.00

Catalys Pacific and SR One have co-led the ¥6 billion (US$38.2 million) series A fundraising round undertaken by...

Price / article: US$19.00
OR existing subscriber
Related Publications

APER Sep 2024 - China & India: Behind Returns...

Subscribers’ Weekly for the week ending 30th Aug 2024...

Connect With Us

We love to share Asia PE insights and news from time to time. Drop us your email address if you like to hear from us.

Rest assured that your email address will not be shared, as we hate spams as much as you do.